Prestige Consumer Healthcare (PBH) Slipped on Mixed Results and Reduced Guidance
Ariel Investments, an investment management company, released its “Ariel Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Prestige Consumer Healthcare Inc. (PBH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.90 | 1,500 | $50,850.00 | 6,600 | 2018-02-12 | Filing | |
| $37.04 | 3,000 | $111,120.00 | 7,806 | 2018-02-07 | Filing | |
| $35.47 | 4,200 | $148,974.00 | 11,097 | 2018-02-05 | Filing | |
| $35.94 | 7,000 | $251,580.00 | 138,969 | 2018-02-05 | Filing | |
| $35.47 | 7,500 | $266,025.00 | 38,506 | 2018-02-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.00 | 1,678 | $151,020.00 | 17,157 | 2025-03-10 | Filing | |
| $85.39 | 6,297 | $537,700.83 | 18,835 | 2025-03-03 | Filing | |
| $86.30 | 5,683 | $490,442.90 | 18,365 | 2025-02-11 | Filing | |
| $86.82 | 5,400 | $468,828.00 | 18,365 | 2025-02-11 | Filing | |
| $82.64 | 5,662 | $467,907.68 | 320,952 | 2024-11-19 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,592,375 | $100,892,880 | 0.16% | |
| 2. | 786,086 | $49,051,766 | 0.36% | |
| 3. | 590,297 | $36,834,532 | 0.01% | |
| 4. | 509,668 | $31,803,283 | 1.73% | |
| 5. | 379,410 | $23,675,184 | 1.12% |
News See All
Here’s Heartland Value Plus Fund’s Views on Prestige Consumer Healthcare (PBH)
Heartland Advisors, an investment management company, released its “Heartland Value Plus Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds
Prestige Consumer Healthcare Inc.
13 Most Oversold Healthcare Stocks So Far in 2025
The healthcare innovation landscape in 2025 is navigating a complex mix of challenges and opportunities, marked by contrasting trends in fundraising, investment, and technology adoption.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q1 2026 Prestige Consumer Healthcare, Inc. Earnings Conference Call.
Prestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital Age
Prestige Consumer Healthcare Inc. (NYSE:PBH) tops the list for being the most undervalued stocks.
10 Most Undervalued Pharma Stocks to Buy Now
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Prestige Consumer Healthcare’s Fourth Quarter 2025 Earnings Conference Call.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2025 Earnings Call Transcript
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2025 Earnings Call Transcript February 6, 2025Prestige Consumer Healthcare Inc. beats earnings expectations.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's Second Quarter 2025 Earnings Call.
Hedge Fund Resource Center Billionaire Hedge Funds
